Clinical trials
Completed Phase 3 Malaria, Falciparum trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 4 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 3 |
| 2014 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| London School of Hygiene and Tropical Medicine | 8 |
| GlaxoSmithKline | 7 |
| University of Oxford | 7 |
| Medicines for Malaria Venture | 2 |
| Centro Internacional de Entrenamiento e Investigaciones Médicas | 1 |
| Dafra Pharma | 1 |
| Institut de Recherche en Sciences de la Sante, Burkina Faso | 1 |
| National Institute for Medical Research, Tanzania | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novartis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Malaria, Falciparum | 35 |
| Malaria | 24 |
| Anemia | 3 |
| Malaria, Vivax | 3 |
| Protozoan Infections | 2 |
| Asymptomatic Infections | 1 |
| Cardiotoxicity | 1 |
| Hepatitis B | 1 |
| Parasitic Diseases | 1 |
| Sexually Transmitted Diseases | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.